Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
McKinsey
Chinese Patent Office
Chubb
Baxter
Covington
Medtronic
Mallinckrodt
Julphar

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040491

« Back to Dashboard

NDA 040491 describes DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE, which is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from four suppliers. Additional details are available on the DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE profile page.

The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
Pharmacology for NDA: 040491
Suppliers and Packaging for NDA: 040491
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 040491 ANDA Cardinal Health 55154-9371 55154-9371-5 5 VIAL in 1 BAG (55154-9371-5) > 1 mL in 1 VIAL
DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE dexamethasone sodium phosphate INJECTABLE;INJECTION 040491 ANDA Proficient Rx LP 63187-348 63187-348-01 1 KIT in 1 CARTON (63187-348-01) * 10 mL in 1 VIAL, SINGLE-DOSE (0409-1559-10) * .9 mL in 1 PACKET (67777-130-02) * 5 mL in 1 POUCH (53329-820-09) * 2 mL in 1 AMPULE (0409-4713-32) * 1 mL in 1 VIAL (63323-506-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG PHOSPHATE/ML
Approval Date:Apr 11, 2003TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cerilliant
Baxter
Cantor Fitzgerald
Cipla
McKinsey
Daiichi Sankyo
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot